• Researcher Profile

    Rizwan Haq, MD, PhD

    Rizwan Haq, MD, PhD
    Associate Physician, Brigham and Women's Hospital

    Assistant Professor, Harvard Medical School



    Office phone: 617-632-5055
    Fax: 617-632-6727
    Email: rizwan_haq@dfci.harvard.edu
    Website: Haq Lab

    Preferred contact method: email

    View Physician Profile

    Research Department

    Medical Oncology/Molecular and Cellular


    Melanoma, Developmental therapeutics, Targeted therapies

    Dana-Farber Cancer Institute
    450 Brookline Avenue
    Boston, MA 02215


    Dr. Haq is a graduate of the University of Toronto, where he completed his B.Sc. (Hon), and MD/PhD. His PhD was at the Ontario Cancer Institute/Princess Margaret Hospital in the laboratory of Dr Brent Zanke. He completed his clinical training in internal medicine at The Johns Hopkins Hospital in Baltimore, followed by medical oncology training at Dana-Farber Cancer Institute and Massachusetts General Hospital. He joined the laboratory of Dr David E. Fisher, where he conducted translational work in the melanoma; and was an attending oncologist at Massachusetts General Hospital.

    He was recruited back to Dana-Farber Cancer Institute in 2014. His research focuses on resistance to melanoma therapies, including targeted agents and immunotherapies. He has been a contributing author of numerous high profile publications, including those published in Cancer CellNatureProceedings of the National Academy of Sciences USA. At Dana-Farber Cancer Institute, Dr. Haq devotes part of his time to developing the next generation of melanoma therapeutics and translating them to innovative investigator-initiated clinical trials. His clinical practice is dedicated to patients with melanoma. 

View Researcher Directory
View Nurse Directory

Find a Clinical Trial

Support Cancer

Give Now